Robert Michael Savel II
Net Worth

Last updated:

What is Robert Michael Savel II net worth?

The estimated net worth of Mr. Robert Michael Savel II is at least $5,243,016 as of 28 Mar 2022. He owns shares worth $16,024 as insider, has earned $13,692 from insider trading and has received compensation worth at least $5,213,300 in Otonomy, Inc..

What is the salary of Robert Michael Savel II?

Mr. Robert Michael Savel II salary is $521,330 per year as Chief Technical Officer in Otonomy, Inc..

How old is Robert Michael Savel II?

Mr. Robert Michael Savel II is 57 years old, born in 1968.

What stocks does Robert Michael Savel II currently own?

As insider, Mr. Robert Michael Savel II owns shares in one company:

Company Title Shares Price per share Total value
Otonomy, Inc. (OTIC) Chief Technical Officer 145,735 $0.11 $16,024

What does Otonomy, Inc. do?

Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. It also develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Robert Michael Savel II insider trading

Otonomy, Inc.

Mr. Robert Michael Savel II has made 5 insider trades between 2015-2022, according to the Form 4 filled with the SEC. Most recently he sold 3,325 units of OTIC stock worth $8,023 on 28 Mar 2022.

The largest trade he's ever made was exercising 25,000 units of OTIC stock on 15 Jun 2015. As of 28 Mar 2022 he still owns at least 145,735 units of OTIC stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 3,325 $2.41 $8,023
Sale
Common Stock 2,374 $2.39 $5,669
Option
Employee Stock Option (right to buy) 5,000 $4.05 $20,225
Sale
Common Stock 5,000 N/A N/A
Option
Employee Stock Option (right to buy) 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Employee Stock Option (right to buy) 5,000 N/A N/A
Option
Common Stock 5,000 $4.05 $20,225
Option
Employee Stock Option (right to buy) 5,000 $4.05 $20,225
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 25,000 N/A N/A
Option
Employee Stock Option (right to buy) 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A

Otonomy key executives

Otonomy, Inc. executives and other stock owners filed with the SEC: